clinical

Peter Y. Chang, MD, is Co-President and Partner at Massachusetts Eye Research & Surgery Institution (MERSI) in Waltham, MA. Dr. Chang specializes in ocular inflammatory disease and vitreoretinal surgery.

Articles

Underlying autoimmune disease alters uveitis therapy.

Autoimmune disease and the eye: Current thinking and approaches to treatment

Cheryl Guttman is a medical writer based in Deerfield, Ill.

XIPERE, the first therapy utilizing the suprachoroidal space, demonstrates rapid efficacy, durable benefit, and favorable safety profile.

FDA approves XIPERE injection for treatment of uveitic macular edema

Videos

Ankur Shah, MD, discusses key highlights of his presentation titled "YUTIQ CALM: a real-world registry study of the fluocinolone acetonide intravitreal implant 0.18 mg in chronic non-infectious posterior uveitis," during ASRS 2021. 

Dissecting real-world registry study of YUTIQ for chronic non-infectious posterior uveitis

Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of 

Anterior uveitis therapy offers anti-inflammatory effect after dosing is stopped.

Tumor necrosis factor α inhibitor reduced anterior chamber inflammation, studies find

Quan Dong Nguyen, MD, MSc, FARVO, FASRS, speaks on the highlights of his presentation regarding new biological treatments of posterior uveitis.

Exploring new biological treatments in posterior uveitis

Study examines immunomodulatory as a potential long-term treatment option.

Adeno-associated virus gene therapy zeroes in on autoimmune uveitis 

Long-term sustained-release therapy pays off in management of chronic, vision-threatening disease.

Sustained-release anti-inflammatory therapy is valuable in noninfectious uveitis

While operating on a patient with chronic uveitis presents some challenges, there are a few pearls that may increase success.

Successful ocular surgery in patients with chronic uveitis

Measures of inflammation can predict treatment outcomes for patients

Measuring intraocular inflammation with standard care imaging

Standardization of Uveitis Nomenclature (SUN) Working Group utilized machine learning to create new uveitis classification criteria, inciting hope for implementation in clinical and research settings.